| 101 |
16518417 | Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines. | 2006 Apr 20 |
3 |
| 102 |
16529740 | Two distinct steps of Bak regulation during apoptotic stress signaling: different roles of MEKK1 and JNK1. | 2006 May 15 |
1 |
| 103 |
16596182 | Cellular components involved in the cell death induced by cisplatin in the absence of p53 activation. | 2006 May |
2 |
| 104 |
16619517 | C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines. | 2006 Mar-Apr |
5 |
| 105 |
16951204 | Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. | 2006 Sep 1 |
2 |
| 106 |
16984892 | c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. | 2006 Nov 17 |
1 |
| 107 |
15841377 | Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment. | 2005 Aug |
4 |
| 108 |
16038800 | Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase. | 2005 Oct |
2 |
| 109 |
16082193 | Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. | 2005 Sep |
1 |
| 110 |
16105650 | Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: a role of c-Jun NH2-terminal kinase 1. | 2005 Oct 7 |
13 |
| 111 |
16238095 | Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity. | 2005 |
1 |
| 112 |
16357177 | Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. | 2005 Dec 15 |
1 |
| 113 |
14722256 | Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines. | 2004 Jan |
4 |
| 114 |
15001534 | Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis. | 2004 Jul |
1 |
| 115 |
15254743 | Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells. | 2004 Aug |
1 |
| 116 |
15386344 | Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. | 2004 Dec 20 |
9 |
| 117 |
15604295 | Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. | 2004 Dec 15 |
1 |
| 118 |
12637505 | Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. | 2003 May 23 |
12 |
| 119 |
12663670 | The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. | 2003 Jun 6 |
1 |
| 120 |
12697749 | AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. | 2003 Jun 27 |
4 |
| 121 |
14520687 | Inhibition of JNK signaling diminishes early but not late cellular stress-induced apoptosis. | 2003 Nov 20 |
1 |
| 122 |
12018840 | Signaling and function of caspase and c-jun N-terminal kinase in cisplatin-induced apoptosis. | 2002 Apr 30 |
5 |
| 123 |
12149148 | An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation. | 2002 Jul |
3 |
| 124 |
12181446 | Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells. | 2002 Sep |
5 |
| 125 |
11340162 | Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner. | 2001 Jun |
1 |
| 126 |
11396136 | Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line. | 2001 Mar-Apr |
1 |
| 127 |
11592233 | Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. | 2001 Oct |
1 |
| 128 |
30147474 | Activation of the JNK/SAPK and P38 Mitogen-Activated Protein Kinase Signaling Pathways Sensitize Tumor Cells to Cisplatin-Induced Apoptosis. | 2001 |
1 |
| 129 |
10639576 | Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells. | 2000 Feb |
1 |
| 130 |
11064451 | CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. | 2000 Oct 26 |
4 |
| 131 |
11170260 | Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. | 2000 Dec |
17 |
| 132 |
9926932 | ASK1 mediates apoptotic cell death induced by genotoxic stress. | 1999 Jan 7 |
2 |
| 133 |
10098743 | Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. | 1999 Mar |
6 |
| 134 |
10353733 | Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. | 1999 May |
4 |
| 135 |
10531373 | Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. | 1999 Oct 29 |
6 |
| 136 |
9484843 | Cisplatin induces a persistent activation of JNK that is related to cell death. | 1998 Jan 29 |
3 |
| 137 |
10081494 | EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway. | 1998 Dec |
2 |
| 138 |
9162025 | The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. | 1997 May 30 |
4 |
| 139 |
9242457 | Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. | 1997 Aug 1 |
6 |
| 140 |
9252645 | The Ras farnesylation inhibitor BZA-5B increases the resistance to cisplatin in a human melanoma cell line. | 1997 Jul-Aug |
2 |